Gastric Cancer Surgery During the Pandemic: What It Costs?

Hilmi YaziciAyse ErenTevfik Kivilcim UprakCihan SahanAhmet Cem EsmerSevket Cumhur Yegen

Published in: Journal of gastrointestinal cancer (2021)

Because of COVID-19's heavy burden on healthcare system, delays in the diagnosis and treatment of oncological patients may occur. Therefore, this may be affected pathological and survival outcomes of cancer patients. Finally, further investigations are needed.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
minimally invasive
prognostic factors
prostate cancer
risk factors
coronary artery bypass
rectal cancer
coronary artery disease